OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Posting of Annual Report and confirmation of AGM
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health and Nutrition products, confirms that the Notice of Annual General Meeting ('AGM') along with the Annual Report and Accounts for the year ended 31 March 2023 has been posted to shareholders on Friday afternoon and will shortly be made available on the Company's website at:
As previously announced, the AGM of the Company will be held on Wednesday 6 September 2023 at 11.00am at Poets House, St Mary's Street, Ely, CB7 4EY.
Contacts:
| Omega Diagnostics Group PLC | ||
| Jag Grewal, Chief Executive Officer | via Walbrook PR | |
| Chris Lea, Chief Financial Officer | | |
| | | |
| finnCap Ltd | Tel: 020 7220 0500 | |
| Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance) | | |
| Nigel Birks / Harriet Ward (ECM) | | |
| | | |
| Walbrook PR Limited | Tel: 020 7933 8780 or omega@walbrookpr.com | |
| Paul McManus / Lianne Applegarth | Mob: 07980 541 893 / 07584 391 303 | |
| Sam Allen | Mob: 07502 558 258 | |
| | | |
About Omega Diagnostics Group PLC
Omega manufactures and distributes high quality in-vitro diagnostic products for use in hospitals, clinics, laboratories and healthcare practitioners in over 85 countries and is now focused on the health and nutrition sector.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.